InvestorPlace - Stock Market News, Stock Advice & Trading Tips
MBRX stock results show that Moleculin Biotech beat analyst estimates for earnings per share the first quarter of 2024.
The post MBRX Stock Earnings: Moleculin Biotech Beats EPS for Q1 2024 appeared first on InvestorPlace.
More From InvestorPlace